Immunocore Holdings plc - Ordinary shares (IMCR)

Historical Holders from Q1 2021 to Q3 2025

Symbol
IMCR on Nasdaq
Type / Class
Equity / Ordinary shares
Shares outstanding
49.9M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
49.2M
Holdings value
$1.79B
% of all portfolios
0.003%
Grand Portfolio weight change
+0%
Number of holders
130
Number of buys
58
Number of sells
-64
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Immunocore Holdings plc - Ordinary shares (IMCR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
T. Rowe Price Investment Management, Inc. 14.1% $213M 7.05M T. Rowe Price Investment Management, Inc. 31 Mar 2025
WELLINGTON MANAGEMENT GROUP LLP 10.2% +12.2% $177M $21.3M 5.13M +13.7% Wellington Management Group LLP 31 Jul 2025
Jallal Bahija 8.2% $136M 4.49M Jallal Bahija 31 Dec 2024
PRIMECAP MANAGEMENT CO/CA/ 7.51% +43.6% $130M $38.2M 3.77M +41.4% PRIMECAP MANAGEMENT CO/CA/ 30 Jun 2025
Bellevue Group AG 5.6% $102M 2.8M Bellevue Group AG 20 Aug 2025
TANG CAPITAL MANAGEMENT LLC 5.2% $94.7M 2.61M TANG CAPITAL MANAGEMENT, LLC 17 Oct 2025

Institutional Holders of Immunocore Holdings plc - Ordinary shares (IMCR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 49.2M $1.79B +$50.9M $36.33 130
2025 Q2 47.8M $1.5B +$18M $31.38 132
2025 Q1 47.3M $1.4B +$60.3M $29.67 115
2024 Q4 45.4M $1.34B -$4.92M $29.50 114
2024 Q3 45.3M $1.41B +$61.1M $31.13 129
2024 Q2 43.1M $1.46B -$99.8M $33.89 135
2024 Q1 41.2M $2.68B +$239M $65.00 149
2023 Q4 37.5M $2.56B +$32.9M $68.32 133
2023 Q3 36.9M $1.92B +$85.5M $51.90 125
2023 Q2 35.3M $2.12B +$164M $59.96 118
2023 Q1 32.7M $1.61B +$119M $49.44 108
2022 Q4 30.3M $1.73B +$218M $57.07 103
2022 Q3 26.4M $1.24B +$262M $46.94 83
2022 Q2 21M $785M +$56.6M $37.31 66
2022 Q1 19.7M $590M +$57.8M $29.90 57
2021 Q4 17.1M $587M +$22M $34.24 45
2021 Q3 16.7M $617M +$83.1M $37.07 46
2021 Q2 13.8M $538M +$10.2M $39.05 41
2021 Q1 14.1M $598M +$598M $42.57 41